Baseimmune utilizes a proprietary AI platform to design mutation-resistant vaccines by modeling pathogen evolution and immune responses. The company addresses the challenge of vaccine efficacy against emerging and complex pathogens that traditional methods fail to target.

Cogitat develops AI-driven software that decodes electroencephalogram (EEG) signals to convert brain waves into digital commands, enabling seamless interaction with devices. This technology addresses the limitations of existing EEG systems by providing a robust, device-agnostic solution that enhances accessibility in virtual reality and wearable applications.

The startup offers a digital consent and booking platform that enables practitioners to create, brand, and manage unlimited treatment consent forms electronically. This solution eliminates the need for paper documentation, streamlining administrative tasks and allowing healthcare providers to focus more on patient care.

Inoviv provides end‑to‑end targeted proteomics services for pharma and biotech companies, delivering pre‑validated or custom multiplexed LC‑MS biomarker panels that quantify proteins, PTMs, lipids, and metabolites with absolute accuracy down to pg/mL. Their CLIA‑ and GLP‑certified workflow includes sample preparation, proprietary standards, high‑throughput LC‑MS/MS analysis, and bioinformatics reporting, enabling rapid biomarker validation, treatment monitoring, patient stratification, and companion diagnostic development.

LabGenius Therapeutics provides the EVA™ platform, a closed‑loop discovery engine that integrates machine‑learning‑based in silico design with automated high‑throughput cell‑based screening to create multispecific therapeutic antibodies. The system employs multi‑objective Bayesian optimization to simultaneously maximize potency, selectivity, and developability across formats such as bispecifics, trispecifics, ADCs, and cell engagers, delivering IND‑ready candidates in under six weeks.

Lydia AI is an artificial intelligence platform that generates personalized and predictive health scores by analyzing data from electronic health records, claims, and other health-related sources. This technology enables health insurers to underwrite policies with increased speed and accuracy, improving risk assessment and customer engagement.

Nutropy utilizes precision fermentation to produce bioidentical milk ingredients from programmed yeast, enabling the creation of animal-free cheese alternatives. This approach significantly reduces resource consumption, greenhouse gas emissions, and eliminates lactose and cholesterol, addressing the environmental and health impacts of traditional dairy farming.

Ochre Bio develops a deep phenotyping platform that utilizes human models to generate genomic and phenotypic data at scale, enabling the rapid development of RNA therapies for chronic liver disease. This approach addresses the rising prevalence of liver disease, which is a leading cause of premature death globally, by providing targeted treatments for patients with late-stage conditions.

Percepto offers an autonomous drone‑in‑a‑box system paired with its AIM AI‑driven analytics platform to perform continuous, remote inspections of industrial assets. The hardware launches, lands, and recharges without human intervention, while the software captures high‑resolution data, detects defects, gas leaks, and creates 3‑D models, delivering actionable insights through a cloud‑based dashboard and real‑time alerts. This solution reduces inspection costs, improves safety, and enables proactive maintenance for utilities, mining, oil & gas, solar farms, and other critical infrastructure operators.

Q Bio builds a clinical digital twin for each individual by aggregating full-body MRI, EKG, genetics, vital signs, and wearable data into a single platform. Its AI‑driven analytics generate personalized health forecasts and trend visualizations, which clinicians can explore through an immersive 3D interface covering nine biological subsystems and use to guide preventive care decisions.

Scantrust offers a software platform for anti-counterfeiting and product traceability, using secure data carriers on product packaging and labels. Their system helps brands combat counterfeiting, track products through the supply chain, and facilitate communication with end-users by providing access to product details. This enables businesses to protect revenue and brand reputation while meeting regulatory requirements.

Senzo Health has developed the Amplified Lateral Flow (ALF) platform, which provides PCR-accurate diagnostics for infectious diseases with results available in under 10 minutes and at a significantly lower cost than traditional laboratory tests. This technology addresses the need for rapid, accessible testing in both clinical and home settings, enabling earlier diagnosis and treatment of prevalent diseases.

The startup operates a soil analytics engine that utilizes proprietary soil DNA extraction and sequencing to quantify microbial populations and analyze soil chemistry. This technology provides farmers with precise soil insights, enabling them to optimize costs, manage risks, and maintain soil health as a valuable asset.